Abstract:ObjectiveTo explore the clinical effects of treatment primary nephrotic syndrome by tacrolimus.Methods30 cases clinical data of primary nephrotic syndrome patients in our hospital department of nephrology from February 2011 to March 2015 were selected,and divided into two groups by different treatment methods,the control group(cytoxan compared with prednisone acetate treatment)15 cases and the Tacrolimus group (prednisone acetate compared with tacrolimus treatment)15 cases.The serum albumin,creatinine,cholesterol,triglyceride,urine protein quantitation of two groups primary nephrotic syndrome patients before treatment and after treatment 6 moths were compared,clinical curative effect of two groups primary nephrotic syndrome patients were compared.ResultsThe serum albumin,creatinine, cholesterol,triglyceride,urine protein quantitation of two groups primary nephrotic syndrome patients before treatment were no significant difference(P>0.05),the serum albumin of control group and Tacrolimus group after treatment 6 moths were higher than before treatment;the creatinine,cholesterol,triglyceride,urine protein quantitation were lower than before treatment;the serum albumin of Tacrolimus group after treatment 6 moths was higher than that of control group;the creatinine,cholesterol,triglyceride,urine protein quantitation were lower than that of control group;the remission rate of treatment group was higher than that of control group,the differences were significant(χ2=7.65,P<0.05).ConclusionThe clinical symptoms of treatment primary nephrotic syndrome by tacrolimus is obviously,remission rate is high,it is worth to be used.
Cross NB,Webster AC,Mas son P,et al.Antihypertensives forkidney transplantrecipients:systematic review and metaanalysis of randomized controlled trials[J].Transplantation,2009,88(1):7-18.
Leroy S,Isapof A,Fargue S,et al.Tacrolimus nephrotoxicity:bew are of the association of diarrhea,drug interaction and pharmacogenetics[J].Pediatr Nephrol,2010,25(5):965-969.
Kang SY,Sohn KH,Lee JO,et al.Intravenous tacrolimus and cyclosporine induced anaphylaxis:what is next[J].Asia Pac Allergy,2015,5(3):181-186.
[7]
Ueda Y,Uemoto S.Decreased tacrolimus concentration following a temporal increase during interferon-free therapy with asunaprevir and daclatasvir in patients with recurrent hepatitis C after liver transplantation[J].Transpl Int,2016,29(1):119-121.
[9]
Hoorn EJ,Walsh SB,Mccormick JA,et al.The calcineurin in-hibitor tacrolimus activates the renal sodium chloride cotrans-porter to cause hypertension[J].Nat Med,2011,17 (10):1304-1309.
[11]
Aydogan M,Yologlu N,Gacar G,et al.Successful rapid rituximab desensitization in an adolescent patientwith nephrotic syndrome:increase in number of Treg cells after desensitization[J].J Allergy Clin Immunol,2013,132(2):478-480.